Analyst Ratings for Jazz Pharmaceuticals (JAZZ) [Buys]
JAZZ Rating Summary
JAZZ Price Target Summary
- Highest: $230.00 (Barclays)
- Lowest: $131.00 (UBS)
- Average: $184.58
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$184.58 (+53.3%)
* Over Last 12-Mos
Rating Score: 8.4 / 10 Percentile Rank: 87%
Rating Score: 8.4 / 10 Percentile Rank: 87%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/3/2024 | Baird | Joel Beatty | New Coverage | Outperform (N/A) |
160.00 (N/A) |
123.00 (120.42) |
-2.1% | Details |
12/8/2022 | Goldman Sachs » Updated 3/3/2023 |
Madhu Kumar | Upgrade | Buy (Neutral) |
212.00 (190.00) |
151.10 (120.42) |
-20.3% | Details |